Found 19 matching trials
Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients PHASE3 The objectives of this trial conducted in early Parkinson's Disease (PD) pa...
Show More Location
248.524.01018 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV PHASE2 A phase II, randomized, open-label, two-arm clinical trial evaluating the s...
Show More Learn More & Join Trial
Pramipexole as a Treatment for Cocaine Dependence PHASE1 The purposes of this study are as follows: 1. To assess the cardiovascular ...
Show More Location
Michael E. DeBakey VA Medical Center
Learn More & Join Trial
Bioavailability of Increasing Pramipexole Doses of Oral Extended Release (ER) Tablets in Healthy Male Volunteers PHASE1 The objectives of the studies are:
* To demonstrate similar total exposure...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate in Patients With Parkinsonian Type Disorders PHASE2 A Phase 2 study to evaluate the safety, tolerability and initial efficacy o...
Show More Learn More & Join Trial
Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD). PHASE3 The general aim of this study is to obtain long-term safety and tolerabilit...
Show More Location
248.633.01004 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Bioequivalence Study of Pramipexole Dihydrochloride Extended-release Tablets in Healthy Chinese Subjects PHASE1 The study compared pramipexole dihydrochloride extended-release tablets (Te...
Show More Location
The General Hospital of Western Theater Command PLA
Learn More & Join Trial
Bioequivalence of Pramipexole Extended Release (PPX ER) 1.5mg x 1 Tablet Once Daily (q.d.) vs. PPX ER 0.375mg x 4 Tablets Under Fasted and Fed Conditions in Japanese Healthy Volunteers PHASE1 Bioequivalence between PPX ER 1.5 mg x 1 tablet q.d. and 0.375 mg PPX ER x ...
Show More Location
248.677.001 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Pivotal Study in Advanced Parkinsons Disease Patients PHASE3 The general aim of this trial is to determine the efficacy (as measured by ...
Show More Location
248.525.43005 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID) PHASE4 1. In order to observe the benefit, side effects, and patient preference of...
Show More Location
Seoul National University Hospital
Learn More & Join Trial